Boston, MANCT05356117Now EnrollingIRB Ready

Pancreatic Cancer Clinical Trial in Boston, MA

Access cutting-edge pancreatic cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Dana-Farber Cancer Institute

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access pancreatic cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pancreatic cancer treatment provided free

Apply for This Boston Location

Check if you qualify for this pancreatic cancer clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Pancreatic Cancer Study in Boston

The purpose of this research is to determine whether a virtually supervised resistance exercise (RE) intervention combined with protein supplementation (PS) is feasible in pancreatic cancer patients initiating chemotherapy and if it will improve skeletal muscle mass. The names of the study interventions involved in this study are: * Resistance training and protein supplement intake (RE + PS) * Resistance training (RE) * Attention control (AC), home-based stretching

Sponsor: Dana-Farber Cancer Institute

Who Can Participate

Inclusion Criteria

Non-metastatic pancreatic cancer patients initiating neoadjuvant chemotherapy.
Ability to understand and the willingness to sign a written informed consent document.
Over the age of 18 years; children under the age of 18 will be excluded due to rarity of disease.
Speak English or Spanish.
Able to provide physician clearance to participate in the exercise program.
Able to initiate a supervised exercise program (free from any cardiovascular, respiratory or musculoskeletal disease or joint problems that preclude moderate physical activity).
Currently participate in less than or equal to 60 minutes of structured moderate or vigorous exercise/week.
Does not smoke (no smoking during previous 12 months).
Willing to travel to DFCI for assessments.

Exclusion Criteria

Patients should not have any uncontrolled illness including ongoing or active infection, uncontrolled diabetes, hypertension or thyroid disease.
Patients may not be receiving any other investigational agents.
Patients with other active malignancies are ineligible for this study.
Patients with metastatic disease.
History of any musculoskeletal, cardiorespiratory or neurological diseases that preclude the participation in exercise.
Patients expected to receive other cancer directed treatments during the study and assessment period.
Participates in more than 60 minutes of structured moderate or vigorous exercise/week.
Currently smokes.
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Is unable to travel to DFCI for assessments.
Patients who are pregnant due to the unknown effects of exercise on the developing fetus.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT05356117) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pancreatic Cancer Treatment Options in Boston, MA

If you're searching for pancreatic cancer treatment options in Boston, MA, this clinical trial (NCT05356117) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pancreatic cancer clinical trials near you to find additional studies recruiting in your area.

More Pancreatic Cancer Trials in Boston, MA

See all pancreatic cancer clinical trials recruiting in Boston — not just this study.

Browse Pancreatic Cancer Trials in Boston →

Browse More Trials by Condition

Pancreatic Cancer TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA